Moderna Shares, Other Covid Vaccine Makers Hit by Warning From Pfizer
13 Diciembre 2023 - 7:31AM
Noticias Dow Jones
By Will Feuer
Shares of Moderna and other makers of Covid-19 vaccines were
dragged lower after rival Pfizer warned that it expects revenue
from its Covid-19 products to fall next year.
Moderna shares were down nearly 5% at $74.51 in premarket
trading, following Pfizer shares, which were more than 6% lower.
Shares of Moderna have already fallen nearly 57% this year.
American depositary receipts tied to shares of Germany-based
BioNTech, which has partnered with Pfizer on its Covid-19 vaccine,
fell about 4% to $95.00 in the premarket session. The stock is down
about 34% this year.
Shares of Novavax also fell about 1% to $5.25 in premarket
trading, adding to a decline of about 48% this year.
Earlier Wednesday, Pfizer issued revenue and earnings outlook
for next year that fell below Wall Street analysts' expectations.
The miss was largely driven by declining sales of the company's
Covid-19 vaccine and its Paxlovid treatment.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
December 13, 2023 08:16 ET (13:16 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
BioNTech (NASDAQ:BNTX)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
BioNTech (NASDAQ:BNTX)
Gráfica de Acción Histórica
De May 2023 a May 2024